Recruiting nowN/AAges 18 Years and up
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
Sponsor: University Hospital Heidelberg · NCT04219202 on ClinicalTrials.gov ↗
Conditions studied
Sarcoma,Soft Tissue
What it tests
- Proton radiationradiation
- Carbon Ion radiationradiation
Where it's running1 site
1 international site
- Recruiting now
University Hospital of Heidelberg, Radiation Oncology
Heidelberg, Germany 69120
- Matthias Uhl, PD(contact)+49-6221-56[email protected]
- Adriane Hommertgen(contact)+49-6221-56[email protected]
- Katharina Seidensaal, MD(sub investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histologically confirmed retroperitoneal soft-tissue sarcoma which is resectable or marginally resectable * Karnofsky index of ≥ 70% * Age from 18 years * Completed patient information and written consent * ability to give consent Exclusion Criteria: * Stage IV (distant metastases) * Lymphogenic metastasis * Metal implants at the level of the sarcoma, which influence the treatment planning * Previous radiation therapy in the treatment area * Desmoid tumors, peritoneal sarcomatosis, GIST * Simultaneous participation in another clinical study that could influence the results of the respective study * Active medical implants for which there is no license for ion irradiation at the time of treatment (e.g. pacemaker, defibrillator) * Pregnant women
Updated 2026-03-10 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.